Company intelligence / Profile preview

Diabeter

Rotterdam, Netherlands

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Diabeter is an independent Dutch chain of leading treatment centers specializing in comprehensive, personalized, and technologically advanced care for children and adults with type 1 diabetes. The company operates several clinics throughout the Netherlands and is recognized for outcome-based care, digital diabetes monitoring, and research collaborations. Diabeter was acquired by Medtronic in 2015 and functions as an innovative center of excellence in diabetes care.

Therapeutic areas: Endocrinology
Modalities: Non-pharmacological therapyDevice
Industry: Non-Academic Healthcare

Partnerships

Medtronic

Beyond the preview

Go deeper on Diabeter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diabeter.

Explore the full profile